1-3 of 3
Krystal Sandza
Close
Sort by
Journal Articles

Vector Shedding and Blood Biodistribution in Patients with Severe Hemophilia a Following Administration of Valoctocogene Roxaparvovec

Annie Clark, PhDPharmD, Kevin Hammon, Krystal Sandza, Richard Torres, Elli Koziol, Jennifer Holcomb, Benjamin Kim, MD, Kala Jayaram, MD, Chris Russell, PhD, Christian Vettermann, PhD, Joshua Henshaw, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 21.
https://doi.org/10.1182/blood-2020-136459
Published: 2020
Journal Articles

Impact of Pre-Existing Immunogenicity to AAV on Vector Transduction By Bmn 270, an AAV5-Based Gene Therapy Treatment for Hemophilia A

Brian Long, PhD MS, BSMedTech, Krystal Sandza, Jennifer Holcomb, Juli Pherarolis, Lucy Crockett, Lillian Falese, Greg Hayes, Jeremy Arens, Charles A. O'Neill, Nancy Pryer, Carlos Fonck, Stephen Zoog, Christian Vettermann
Journal: Blood
Blood (2017) 130 (Supplement 1): 3332.
https://doi.org/10.1182/blood.V130.Suppl_1.3332.3332
Published: 2017
Journal Articles

Human Factor VIII Expression and Normalization of Bleeding Following AAV Gene Therapy in a Double Knockout Mouse Model of Hemophilia

Stuart Bunting, PhD, Lening Zhang, PhD, Lin Xie, BS, Sherry Bullens, AB, Rajeev Mahimkar, PhD, Sylvia Fong, PhD, Krystal Sandza, BS, Peter Colosi, PhD, Shinong Long, PhD, Gordon Allen Vehar, PhD, Barrie Carter, PhD
Journal: Blood
Blood (2015) 126 (23): 3239.
https://doi.org/10.1182/blood.V126.23.3239.3239
Published: 2015